Navigation Links
Michigan Passes Legislation to License Physical Therapist Assistants
Date:6/30/2009

LANSING, Mich., June 30 /PRNewswire/ -- Michigan Governor Jennifer M. Granholm signed SB 151 into law last week, requiring physical therapist assistants (PTAs) to obtain state licensure. Michigan is now the 48th state to regulate PTAs, according to the Michigan Physical Therapy Association (MPTA).

Licensure for PTAs guarantees that they will have the necessary education and training, and promotes the highest degree of public protection.

This is a law that protects jobs. There are approximately 4,000 PTAs in Michigan. Licensure will keep qualified PTAs working in Michigan.

"Our efforts to ensure that physical therapy patients will receive the highest quality care from PTAs have paid off," said Michigan Physical Therapy Association President Kathleen "Jake" Jakubiak Kovacek, PT. "We're grateful that our lawmakers recognized the importance of this legislation in patient protection."

Jakubiak Kovacek expressed gratitude to State Senator Bruce Patterson (R-Canton) who sponsored the bill, State Senator Tom George (R-Kalamazoo) who ensured quick passage through the Senate Health Policy Committee, State Representative Marc Corriveau (D-Northville) who guided it through the House Health Policy Committee and State Representative Kathy Angerer (D-Dundee) who shepherded the bill on the House Floor.

The Michigan Board of Physical Therapy and the Michigan Department of Community Health will move forward with the process of promulgating administrative rules, creating a limited license, and distributing the limited license to qualified PTAs by December 31, 2009. A permanent license will follow.

The Michigan Department of Energy Labor & Economic Growth (DELEG)/ Bureau of Labor Market Information and Strategic Initiatives reports that the Michigan employment outlook to 2016 predicts a 22% growth in PT jobs and 29% growth in PTA jobs state wide.


'/>"/>
SOURCE Michigan Physical Therapy Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Hospice of Michigan President and CEO Available for Comment on New England Journal of Medicine Article on Profits in Hospice Industry and Proposed Changes From MedPAC
2. Michigan Health & Hospital Association Elects 2009 Officers and Board Members
3. Michigan Among Top Three E-Prescribing States in the Nation, Led by Automotive Company Initiative
4. Covenant Medical Center CEO Spencer Maidlow is Named Michigans Top Hospital and Patient Care Advocate for 2009
5. Blue Cross Blue Shield of Michigan Concludes Autism Lawsuit with Settlement Focused on Families Who Received Early Intervention Services, Not Attorneys
6. Blue Cross Blue Shield of Michigan Forced to Pay for Autism Care In Landmark Case
7. Carol Horowitz of East Lansing Installed as President of Michigan State Medical Society Alliance
8. Michigan State Medical Society Collaborates With Microsoft to Expand Health Care Technology in Michigan
9. Proposed Senate Health Care Cuts Will Reduce Health Care Access for All Michigan Citizens
10. Blue Cross Blue Shield of Michigan and Blue Care Network Launch Web Sites to Help General Motors Members Easily Find Information on Their Health Care
11. Three Michigan Companies Expand in Ann Arbor with MEDC Support
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Study highlights implications of influenza pandemics on blood supplies 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 2Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 3Health News:AUL Action: Senate Health Bill Now Leads to Unprecedented Federal Abortion Funding 4Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 2Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 3Health News:Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools 4Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 2Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 3Health News:Shoppers Cautioned Against Poisoning With Holiday Gifts 4
Breaking Medicine Technology:Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 2Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 3Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 4Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 5Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 6Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 7Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 8Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 9Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis 10Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 1Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 2Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 3Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 4Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 1Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 2Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 3Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 4Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 1Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 2Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 3
Other Medicine Technology:Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer 4Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 2Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 3Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 4Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 5Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 6Phase 1 & 2 Data of Perifosine (KRX-0401) in Patients with Advanced Renal Cell Carcinoma Presented Today at the 25th Annual Chemotherapy Foundation Symposium 7